CMC Europe
- Company typePrivate
- Founded2019
- HeadquartersBudapest, Hungary
- Headcount11–50
- GTM typeB2B
- OfferingServices
CMC Europe firmographics
Firmographics- Name
- CMC Europe
- Website
- https://cmc-europe.eu
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
CMC Europe industry classification
Industry- Product category
- Undetermined
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industry
- CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC) (HLAGAKAB)
Keywords
Where CMC Europe is headquartered
LocationHeadquarters
- HQ city
- Budapest
- HQ country
- Hungary
- HQ region
- Europe
Markets served
CMC Europe business model
Business model- GTM type
- B2B
- Offering type
- Services
CMC Europe product offering
Product offeringCore offering
CMC Europe's core offering cannot be determined from the available source data. The company website is under development and displays only a placeholder page with the company logo and a contact email address ([email protected]). No products, services, or commercial offerings are described in the available source material.
Product overview
No product or service information available. The CMC Europe website is currently under development with only a placeholder page displaying the company logo and contact email ([email protected]). No products, services, or offerings are described in the available source data.
Differentiator
Problem solved
Functional benefit
Companies that use CMC Europe
Customer profileIdeal customer profiles1 record
CMC Europe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CMC Europe competitors and assessment
Company assessmentBroad incumbents
- Recipharm: Large European CDMO offering CMC development, manufacturing, and regulatory services — broader portfolio but overlapping core capability with a CMC consulting/services firm.
- Aenova: Major European CDMO with CMC and pharmaceutical development capabilities, serving similar biotech and pharma clients with a much broader service portfolio.
- Thermo Fisher Scientific (Patheon CDMO): World-leading CDMO offering end-to-end CMC, analytical, and regulatory services; provides the competitive ceiling against which European boutique CMC firms must position.
- Catalent (Novo Holdings): Global CDMO with significant CMC development, formulation, and regulatory support offerings — comparable end-services but at vastly larger scale.
Direct peers
- Simbec-Orion: European clinical and regulatory services provider offering CMC and regulatory support to biotechs; comparable boutique-mid-market positioning and customer profile.
- PharmaLex (Cencora): Global pharma regulatory and CMC consulting firm with strong European footprint, offering CMC, Module 3 support, and regulatory affairs services to biotech and mid-pharma — directly comparable service mix to a CMC-focused European boutique.
- Voisin Consulting Life Sciences: European-headquartered consultancy specialised in CMC, regulatory affairs, and scientific advice for pharma/biotech — same niche positioning and client base as a presumed CMC Europe.
Regional players
- FGK Clinical Research: European CRO/CDMO-adjacent services firm based in Germany with strong Central/Eastern European operations, comparable in scale and life-sciences services focus to a Budapest-based boutique.
Others
- Adare Pharma Solutions: US-headquartered CDMO with European operations offering formulation, CMC development, and manufacturing services — overlapping CMC capability.
Emerging players
- Pharmapace (a Veramed Group company): Smaller European biostatistics and regulatory/CMC-adjacent services firm, comparable boutique scale and EU biotech target customer base to a presumed CMC Europe.
Market position
Strengths3 records
Weaknesses2 records
Key risks4 records
Key highlights3 records
Customer concentration
CMC Europe social profiles
Digital presenceCMC Europe financial estimates
Financial estimateRevenue estimate
Valuation estimate
CMC Europe leadership team
Management profileNumber of profiles
CMC Europe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CMC Europe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CMC Europe
What does CMC Europe do?
CMC Europe's core offering cannot be determined from the available source data. The company website is under development and displays only a placeholder page with the company logo and a contact email address ([email protected]). No products, services, or commercial offerings are described in the available source material.
Is CMC Europe a public or private company?
CMC Europe is a private company. It is classified as unknown and is currently operating.
When was CMC Europe founded?
CMC Europe was founded in 2019. It employs 11 to 50 people.
Where is CMC Europe based?
CMC Europe is headquartered in Budapest, Hungary, in the Europe region.
Who are CMC Europe's main competitors?
Broad incumbents on record are Recipharm, Aenova, Thermo Fisher Scientific (Patheon CDMO) and Catalent (Novo Holdings). Direct peers are Simbec-Orion, PharmaLex (Cencora) and Voisin Consulting Life Sciences. FGK Clinical Research is listed as a regional player. Adare Pharma Solutions is listed as an others. Pharmapace (a Veramed Group company) is listed as an emerging player.
Does CMC Europe have an API?
No public API is recorded for CMC Europe.
What industry is CMC Europe in?
CMC Europe's product category is Undetermined. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAKAB, CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC). Its NAICS code is 54169.